| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, CHEWABLE / ORAL | 11.8 mg | | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, COATED PELLETS / ORAL | 3.32 mg | | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, EXTENDED RELEASE / ORAL | 119.7 mg | | Exact identifier — unii+route 34 equally ranked IID candidates |
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | POWDER, FOR SUSPENSION / ORAL | | 600 mg | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER, FOR SUSPENSION / ORAL | | 2553 mg | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION / ORAL | | 305 mg | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | GRANULE, FOR SUSPENSION / ORAL | 1.7 mg | | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, CHEWABLE / ORAL | 11.8 mg | | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, DELAYED RELEASE / ORAL | | 105 mg | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | GRANULE / ORAL | | 45 mg | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, DELAYED RELEASE / ORAL | | 79 mg | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE / ORAL | | 1488 mg | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE / ORAL | | 1488 mg | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | | 58 mg | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 221 mg | | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | | 582 mg | Exact identifier — unii+route 34 equally ranked IID candidates |
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | POWDER, FOR SUSPENSION / ORAL | | 600 mg | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SYRUP / ORAL | | 250 mg | Exact identifier — unii+route 34 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER, FOR SUSPENSION / ORAL | | 2553 mg | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | GRANULE, FOR SUSPENSION / ORAL | 1.7 mg | | Exact identifier — unii+route 34 equally ranked IID candidates |
| MANNITOL | MANNITOL | 3OWL53L36A | POWDER, FOR SUSPENSION / ORAL | | 7093 mg | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | | 1127 mg | Exact identifier — unii+route 34 equally ranked IID candidates |
| ASPARTAME | ASPARTAME | Z0H242BBR1 | POWDER, FOR SUSPENSION / ORAL | | 420 mg | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| SACCHARIN SODIUM | SACCHARIN SODIUM | SB8ZUX40TY | POWDER, FOR SUSPENSION / ORAL | | 85 mg | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 221 mg | | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | | 58 mg | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, DELAYED RELEASE / ORAL | | 105 mg | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | | 1127 mg | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, EXTENDED RELEASE / ORAL | | 1472 mg | Exact identifier — unii+route 34 equally ranked IID candidates |
| MANNITOL | MANNITOL | 3OWL53L36A | POWDER, FOR SUSPENSION / ORAL | | 7093 mg | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, EXTENDED RELEASE / ORAL | | 1472 mg | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, COATED PELLETS / ORAL | 3.32 mg | | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | | 582 mg | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION / ORAL | | 305 mg | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, ORALLY DISINTEGRATING / ORAL | | 41 mg | Exact identifier — unii+route 34 equally ranked IID candidates |
| SACCHARIN SODIUM | SACCHARIN SODIUM | SB8ZUX40TY | POWDER, FOR SUSPENSION / ORAL | | 85 mg | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| ASPARTAME | ASPARTAME | Z0H242BBR1 | POWDER, FOR SUSPENSION / ORAL | | 420 mg | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, EXTENDED RELEASE / ORAL | 119.7 mg | | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, ORALLY DISINTEGRATING / ORAL | | 41 mg | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SYRUP / ORAL | | 250 mg | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | GRANULE / ORAL | | 45 mg | Exact identifier — unii+route 34 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, DELAYED RELEASE / ORAL | | 79 mg | Exact identifier — unii+route 34 equally ranked IID candidates |